No Data
Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
A Tech Reckoning Is Coming, Financial Pro Says. It's Time to Play Defense.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond
Express News | Cellares: Kite, a Gilead Company, Will Evaluate Co's Automated Manufacturing Platform Cell Shuttle